ArticleAntimicrobial agents and chemotherapy2019
Bicarbonate Resensitization of Methicillin-Resistant
Open access · hybridAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 34 citations in OpenAlex.
- Genomic investigation and clinical correlates of theAntimicrobial agents and chemotherapy · 2024Trial
- Methicillin-resistant Staphylococcus aureus.Nature reviews. Disease primers · 2026Review
- An Achilles' heel for methicillin-resistantAntimicrobial agents and chemotherapy · 2026Review
- Restoration of daptomycin sensitivity with adjunctive cefazolin is associated with C-terminal MprF mutations in MRSA bacteremia isolates.Antimicrobial agents and chemotherapy · 2026Article
- Resistance breakers: a novel approach to tackle biofilm associated infections and antimicrobial resistance.Frontiers in microbiology · 2026Review
- Review
- Genetic Correlates of Synergy Mechanisms of Daptomycin Plus Fosfomycin in Daptomycin-Susceptible and -Resistant Methicillin-ResistantMicroorganisms · 2025Article
- Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2025Article
- NaHCO3 modulates the bla operon and β-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA).The Journal of antimicrobial chemotherapy · 2025Article
- Bicarbonate Within: A Hidden Modulator of Antibiotic Susceptibility.Antibiotics (Basel, Switzerland) · 2025Review
- Sensitizing methicillin-resistantAntimicrobial agents and chemotherapy · 2024Article
- Measuring beta-lactam minimum inhibitory concentrations inJournal of clinical microbiology · 2024Review
- Case report: Methicillin-resistantFrontiers in medicine · 2024Article
- Role of the NaHCOMicrobiology spectrum · 2023Article
- Re-evaluation of FDA-approved antibiotics with increased diagnostic accuracy for assessment of antimicrobial resistance.Cell reports. Medicine · 2023Article
- Impact of Bicarbonate on PBP2a Production, Maturation, and Functionality in Methicillin-ResistantAntimicrobial agents and chemotherapy · 2023Article
- Influence of Sodium Bicarbonate on Wall Teichoic Acid Synthesis and β-Lactam Sensitization in NaHCOMicrobiology spectrum · 2022Article
- The NaHCOAntimicrobial agents and chemotherapy · 2022Article
- Impacts of NaHCOAntibiotics (Basel, Switzerland) · 2022Article
- Bicarbonate modulates delafloxacin activity against MDR Staphylococcus aureus and Pseudomonas aeruginosa.The Journal of antimicrobial chemotherapy · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Selvi C ErsoyLos Angeles Biomedical Research Institute, Torrance, California, USA.
Wessam AbdelhadyLos Angeles Biomedical Research Institute, Torrance, California, USA.
Liang LiLos Angeles Biomedical Research Institute, Torrance, California, USA.
Henry F ChambersDivision of Infectious Diseases, Zuckerberg San Francisco General Department of Medicine, San Francisco School of Medicine, University of California, San Francisco, California, USA.
Yan Q XiongLos Angeles Biomedical Research Institute, Torrance, California, USA yxiong@ucla.edu.
Arnold S BayerLos Angeles Biomedical Research Institute, Torrance, California, USA.
The Lundquist Institute · USUniversity of California, San Francisco · US
Funding
STREPTOCOCCAL PLATELET BINDING AND ENDOCARDITISR01AI041513 · NIAID · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI SULLAM, PAUL M. · 1997 to 2019
$5.6MNovel Mechanisms of Beta-lactam Resistance in Staph AureusR01AI100291 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CHATTERJEE, SOM, HENRY CHAMBERS, HENRY F · 2013 to 2023
$5.1MStaphylococcal Adaptations to Platelet Microbicidal ProteinR01AI039108 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI BAYER, ARNOLD S · 1997 to 2016
$5.1MThe role of purine biosynthesis and stringent response in persistent MRSA endovascular infectionsR01AI139244 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI XIONG, YAN Q. · 2019 to 2023
$2.2MBicarbonate-Mediated Enhancement of Beta-Lactam-MRSA Killing: Mechanisms and Clinical TranslatabilityR01AI146078 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI XIONG, YAN Q. · 2019 to 2023
$1.9MDesign and Development of Immunotolerant S. aureus BiotherapiesR42AI118133 · NIAID · LYTICON, LLC · PI BAILEY-KELLOGG, CHRIS, GRISWOLD, KARL E · 2017 to 2018
$1.5MNovel Mechanisms of Beta-lactam Resistance in Staph AureusR56AI100291 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHATTERJEE, SOM, HENRY CHAMBERS, HENRY F · 2012 to 2017
$1.1MNIAID NIH HHS R01 AI039108NIAID NIH HHS R01 AI041513NIAID NIH HHS R01 AI100291NIAID NIH HHS R01 AI139244NIAID NIH HHS R01 AI146078NIAID NIH HHS R42 AI118133NIAID NIH HHS R56 AI100291
Abstract
Endovascular infections caused by methicillin-resistant
Indexed as
AnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial Proteinsbeta-LactamsBicarbonatesCathelicidinsCefazolinCulture MediaDrug SynergismEndocarditis, BacterialMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsOxacillinPenicillin-Binding ProteinsRabbitsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial Proteinsbeta-LactamsBicarbonatesCathelicidinsCefazolinCulture MediamecA protein, Staphylococcus aureusOxacillinPenicillin-Binding ProteinsSalicylic AcidSarA protein, Staphylococcus aureusantimicrobial susceptibility testinginfective endocarditisMRSApenicillin-binding proteinssodium bicarbonateβ-lactams
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.